Malignant Cerebellar Neoplasm — Trials

Malignant Cerebellar Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

207 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 30
Ph III recruiting: 2
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (28)

clinicaltrialsPublishedShowing 51–73 of 73 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04661384	Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma	active not recruiting	Phase 1	10	City of Hope Medical CenterOTHER	1	Mar 5, 2026	clinicaltrials
NCT05106296	Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer	recruiting	Phase 1	37	Theodore S. JohnsonOTHER	1	Jan 9, 2026	clinicaltrials